The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin
Tuberculosis (TB) remains a large-scale public health problem. Key global priorities for TB care and control include improving case-detection and detecting cases earlier, including cases of smear-negative disease. This document updates existing WHO policy on the use of molecular LPAs for detecting MTBC a...
Técnicas de Sonda Molecular, Rifamicinas/uso terapêutico, Isoniazida/uso terapêutico, Tuberculose Resistente a Múltiplos Medicamentos/diagnóstico, Antituberculosos/uso terapêutico, Isoniazida/farmacologia, Rifampina/farmacologia, Mycobacterium tuberculosis/efeitos dos fármacos, Farmacorresistência Bacteriana, Reprodutibilidade dos Testes